A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

HomeTagsCGM

CGM

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.
Spot_ImgSpot_Img

By using this website you agree to accept Medical Device News Magazine Privacy Policy